PYC Therapeutics Limited

ASX:PYC Stock Report

Market Cap: AU$676.6m

PYC Therapeutics Management

Management criteria checks 4/4

We currently do not have sufficient information about the CEO.

Key information

Rohan Hockings

Chief executive officer

AU$433.2k

Total compensation

CEO salary percentage91.2%
CEO tenure4.3yrs
CEO ownershipn/a
Management average tenure4.3yrs
Board average tenure3.8yrs

Recent management updates

Recent updates

We're Hopeful That PYC Therapeutics (ASX:PYC) Will Use Its Cash Wisely

Oct 25
We're Hopeful That PYC Therapeutics (ASX:PYC) Will Use Its Cash Wisely

Companies Like PYC Therapeutics (ASX:PYC) Are In A Position To Invest In Growth

Apr 10
Companies Like PYC Therapeutics (ASX:PYC) Are In A Position To Invest In Growth

Is PYC Therapeutics (ASX:PYC) In A Good Position To Deliver On Growth Plans?

Nov 10
Is PYC Therapeutics (ASX:PYC) In A Good Position To Deliver On Growth Plans?

We Think PYC Therapeutics (ASX:PYC) Needs To Drive Business Growth Carefully

Jul 03
We Think PYC Therapeutics (ASX:PYC) Needs To Drive Business Growth Carefully

Here's Why We're Watching PYC Therapeutics' (ASX:PYC) Cash Burn Situation

Jan 25
Here's Why We're Watching PYC Therapeutics' (ASX:PYC) Cash Burn Situation

Companies Like PYC Therapeutics (ASX:PYC) Are In A Position To Invest In Growth

Jul 31
Companies Like PYC Therapeutics (ASX:PYC) Are In A Position To Invest In Growth

We're Not Very Worried About PYC Therapeutics' (ASX:PYC) Cash Burn Rate

Mar 28
We're Not Very Worried About PYC Therapeutics' (ASX:PYC) Cash Burn Rate

Non-Executive Chair of the Board Alan Tribe Just Bought A Handful Of Shares In PYC Therapeutics Limited (ASX:PYC)

Feb 20
Non-Executive Chair of the Board Alan Tribe Just Bought A Handful Of Shares In PYC Therapeutics Limited (ASX:PYC)

Have Insiders Been Selling PYC Therapeutics Limited (ASX:PYC) Shares?

Jan 26
Have Insiders Been Selling PYC Therapeutics Limited (ASX:PYC) Shares?

What You Need To Know About PYC Therapeutics Limited's (ASX:PYC) Investor Composition

Dec 22
What You Need To Know About PYC Therapeutics Limited's (ASX:PYC) Investor Composition

We Think PYC Therapeutics (ASX:PYC) Can Easily Afford To Drive Business Growth

Nov 17
We Think PYC Therapeutics (ASX:PYC) Can Easily Afford To Drive Business Growth

CEO Compensation Analysis

How has Rohan Hockings's remuneration changed compared to PYC Therapeutics's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024AU$433kAU$395k

-AU$38m

Mar 31 2024n/an/a

-AU$30m

Dec 31 2023n/an/a

-AU$22m

Sep 30 2023n/an/a

-AU$22m

Jun 30 2023AU$438kAU$395k

-AU$23m

Mar 31 2023n/an/a

-AU$23m

Dec 31 2022n/an/a

-AU$24m

Sep 30 2022n/an/a

-AU$19m

Jun 30 2022AU$418kAU$395k

-AU$14m

Mar 31 2022n/an/a

-AU$15m

Dec 31 2021n/an/a

-AU$17m

Sep 30 2021n/an/a

-AU$17m

Jun 30 2021n/an/a

-AU$18m

Mar 31 2021n/an/a

-AU$15m

Dec 31 2020n/an/a

-AU$12m

Sep 30 2020n/an/a

-AU$9m

Jun 30 2020AU$471kAU$395k

-AU$7m

Mar 31 2020n/an/a

-AU$6m

Dec 31 2019n/an/a

-AU$5m

Sep 30 2019n/an/a

-AU$5m

Jun 30 2019AU$482kAU$395k

-AU$4m

Mar 31 2019n/an/a

-AU$4m

Dec 31 2018n/an/a

-AU$5m

Sep 30 2018n/an/a

-AU$6m

Jun 30 2018AU$377kAU$84k

-AU$7m

Compensation vs Market: Rohan's total compensation ($USD269.74K) is below average for companies of similar size in the Australian market ($USD883.49K).

Compensation vs Earnings: Rohan's compensation has been consistent with company performance over the past year.

CEO

Rohan Hockings (41 yo)

4.3yrs

Tenure

AU$433,210

Compensation

Dr. Rohan Hockings, MBBS (Hons.), J.D., G.D.L.P, has been Chief Executive Officer at PYC Therapeutics Limited since August 2020. He served as Chief Strategy Officer at PYC Therapeutics Limited until August...

Leadership Team

NamePositionTenureCompensationOwnership
Rohan Hockings
CEO & Executive Director4.3yrsAU$433.21kno data
Andrew Taylor
CFO & Company Secretary2.7yrsno datano data
Kevin Hart
Company Secretary7.4yrsAU$165.90kno data

4.3yrs

Average Tenure

Experienced Management: PYC's management team is considered experienced (4.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Rohan Hockings
CEO & Executive Director6.1yrsAU$433.21kno data
Michael Rosenblatt
Independent Non-Executive Director3.8yrsAU$86.67kno data
David Birch
Member of Ophthalmology Clinical Advisory Board3.3yrsno datano data
Jason Haddock
Independent Director3.8yrsAU$86.67kno data
Alan Tribe
Non-Executive Chair of the Board6.7yrsAU$70.00k34.02%
A$ 230.2m
Fred Chen
Member of Scientific Advisory Board & Member of Ophthalmology Clinical Advisory Board5.3yrsno datano data
Mark Pennesi
Member of Ophthalmology Clinical Advisory Board3.3yrsno datano data
Jacque Duncan
Member of Ophthalmology Clinical Advisory Board3.3yrsno datano data

3.8yrs

Average Tenure

65yo

Average Age

Experienced Board: PYC's board of directors are considered experienced (3.8 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 22:07
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

PYC Therapeutics Limited is covered by 6 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Thomas WakimBell Potter
Elyse ShapiroCanaccord Genuity
Michael Thomas CooperEdison Investment Research